WHI-P258
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 406977

CAS#: 21561-09-1

Description: WHI-P258 is a Janus kinase 3 inhibitor. WHI-P131 may provide the basis for the design of new treatment strategies against acute lymphoblastic leukemia, the most common form of childhood cancer.


Price and Availability

Size
Price

25mg
USD 250
200mg
USD 950
2g
USD 3850
Size
Price

50mg
USD 450
500mg
USD 1850
5g
Ask price
Size
Price

100mg
USD 650
1g
USD 2750

WHI-P258, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received. Delivery time: overnight (USA/Canada); 3-5 days (worldwide).


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 406977
Name: WHI-P258
CAS#: 21561-09-1
Chemical Formula: C16H15N3O2
Exact Mass: 281.1164
Molecular Weight: 281.315
Elemental Analysis: C, 68.31; H, 5.37; N, 14.94; O, 11.37


Synonym: WHI-P258; WHI-P 258; WHI-P-258; WHIP 258

IUPAC/Chemical Name: 6,7-Dimethoxy-N-phenylquinazolin-4-amine

InChi Key: MJKCGAHOCZLYDG-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H15N3O2/c1-20-14-8-12-13(9-15(14)21-2)17-10-18-16(12)19-11-6-4-3-5-7-11/h3-10H,1-2H3,(H,17,18,19)

SMILES Code: COC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C, Uckun FM. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res. 1999 Jun;5(6):1569-82. PubMed PMID: 10389946.